{"id":2686,"date":"2022-11-24T14:50:00","date_gmt":"2022-11-24T14:50:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/"},"modified":"2022-11-24T14:50:00","modified_gmt":"2022-11-24T14:50:00","slug":"positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/","title":{"rendered":"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland"},"content":{"rendered":"
\n

Vid konferensen American Heart Association (AHA) 2022, som \u00e4gde rum i Chicago, USA, tidigare denna m\u00e5nad, presenterade professor David Kaye fr\u00e5n The Alfred i Melbourne, Australien, sin erfarenhet fr\u00e5n en p\u00e5g\u00e5ende studie av l\u00e4ngre transporttider av donerade hj\u00e4rtan. De imponerande resultaten visar att det inte f\u00f6rekom n\u00e5gon d\u00f6dlighet bland de f\u00f6rsta 20 studiepatienterna som blev transplanterade med donerade hj\u00e4rtan som bevarats med XVIVOs hj\u00e4rtteknologi, trots de kraftigt f\u00f6rl\u00e4ngda transporttiderna vilka varade upp till 8 timmar och 47 minuter.<\/strong><\/p>\n<\/div>\n

\n

XVIVOs teknologi f\u00f6r att skydda donerade hj\u00e4rtan under transporter best\u00e5r av en maskin, en eng\u00e5ngsartikel samt en patentskyddad l\u00f6sning. Den australiensiska och nyzeel\u00e4ndska pr\u00f6varinitierade studien \u201dMulticenter trial of Extended (6-8 hours) Non-Ischemic Heart Preservation (NIHP) of Donor Hearts for Transplantation\u201d p\u00e5g\u00e5r p\u00e5 5 sjukhus och den sista patienten f\u00f6rv\u00e4ntas vara inkluderad i slutet av 2022. Professor David Kaye och professor David McGiffin fr\u00e5n The Alfred leder studien.<\/p>\n

"Bortsett fr\u00e5n den potentiella skadan som kan uppst\u00e5 n\u00e4r donerade hj\u00e4rtan f\u00f6rvaras utan cirkulation p\u00e5 is, utg\u00f6r tiden som hj\u00e4rtat \u00e4r utanf\u00f6r kroppen ett stort problem. Detta speciellt f\u00f6r l\u00e4nder med stora geografiska avst\u00e5nd, s\u00e5som Australien och Nya Zeeland, d\u00e4r donerade hj\u00e4rtan ej kan transplanteras n\u00e4r den f\u00f6rv\u00e4ntade tiden utanf\u00f6r kroppen bed\u00f6ms bli oacceptabelt l\u00e5ng\u201d, s\u00e4ger professor David Kaye och forts\u00e4tter \u201dprim\u00e4r graftdysfunktion, PGD, \u00e4r en k\u00e4nd komplikation som blir mer vanligt f\u00f6rekommande n\u00e4r tiden utanf\u00f6r kroppen f\u00f6rl\u00e4ngs. D\u00e4rf\u00f6r kan en s\u00e4ker f\u00f6rl\u00e4ngning av tiden som det donerade hj\u00e4rtat kan vara utanf\u00f6r kroppen bortom dagens gr\u00e4ns p\u00e5 4-6 timmar g\u00f6ra att fler donerade hj\u00e4rtan blir tillg\u00e4ngliga f\u00f6r transplantation. Detta har demonstrerats i studien och utan en \u00f6kad risk f\u00f6r dysfunktion. De f\u00f6rsta 20 patienterna som erh\u00e5llit hj\u00e4rtan i studien i Australien och Nya Zeeland \u00e4r samtliga i livet, och trots den l\u00e5nga tiden hj\u00e4rtat bevarats utanf\u00f6r kroppen har endast en patient beh\u00f6vt kortvarigt cirkulationsst\u00f6d efter transplantationen. " En sammanfattning om studien som presenterades vid AHA 2022-m\u00f6tet finns med som en bilaga till detta pressmeddelande.<\/p>\n

"Det \u00e4r mycket gl\u00e4djande att ta del av den prelimin\u00e4ra data som presenterades av professor Kaye. Den blir en viktig milstolpe f\u00f6r oss i att bredda de kliniska bevisen f\u00f6r v\u00e5r unika hj\u00e4rtteknologi. Vi ser betydande m\u00f6jligheter att p\u00e5 ett s\u00e4kert s\u00e4tt f\u00f6rl\u00e4nga tiden f\u00f6r bevarande av donerade hj\u00e4rtan utanf\u00f6r kroppen. Detta kommer att ha en enorm inverkan p\u00e5 den logistiskt utmanande processen f\u00f6r hj\u00e4rttransplantationer och kommer i slut\u00e4ndan g\u00f6ra att fler hj\u00e4rtan blir tillg\u00e4ngliga f\u00f6r transplantation\u201d, s\u00e4ger Christoffer Rosenblad, tillf\u00f6rordnad VD f\u00f6r XVIVO.
\u00a0
24 november, 2022
G\u00f6teborg
Christoffer Rosenblad, tillf\u00f6rordnad VD
XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n\n

Christoffer Rosenblad, Tillf\u00f6rordnad VD, +46 73 519 21 59, e-post: christoffer.rosenblad@xvivogroup.com
Kristoffer\u00a0Nordstr\u00f6m,\u00a0CFO, +46 73 519 21 64, e-post:\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n

\n

Om oss<\/strong><\/p>\n\n

XVIVO grundades 1998 och \u00e4r ett medicintekniskt f\u00f6retag dedikerat till att f\u00f6rl\u00e4nga livet f\u00f6r donerade organ s\u00e5 att transplantationsteam runt om i v\u00e4rlden kan r\u00e4dda fler liv. V\u00e5ra l\u00f6sningar g\u00f6r det m\u00f6jligt f\u00f6r ledande kliniker och forskare att t\u00e4nja p\u00e5 gr\u00e4nserna f\u00f6r transplantationsmedicin.\u00a0XVIVO har sitt huvudkontor i G\u00f6teborg och har kontor och forskningsanl\u00e4ggningar p\u00e5 tv\u00e5 kontinenter. Bolaget \u00e4r noterat p\u00e5 Nasdaq Stockholm\u00a0och handlas under symbolen XVIVO. Mer information finns att l\u00e4sa p\u00e5 hemsidan www.xvivogroup.com\/us<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n\n

Appendix Abstract<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Vid konferensen American Heart Association (AHA) 2022, som \u00e4gde rum i Chicago, USA, tidigare denna m\u00e5nad, presenterade professor David Kaye…<\/p>\n","protected":false},"template":"","class_list":["post-2686","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nPositiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Vid konferensen American Heart Association (AHA) 2022, som \u00e4gde rum i Chicago, USA, tidigare denna m\u00e5nad, presenterade professor David Kaye...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\\\/\",\"name\":\"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-11-24T14:50:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/","og_locale":"en_US","og_type":"article","og_title":"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland - XVIVO","og_description":"Vid konferensen American Heart Association (AHA) 2022, som \u00e4gde rum i Chicago, USA, tidigare denna m\u00e5nad, presenterade professor David Kaye...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/","name":"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-11-24T14:50:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/positiva-resultat-presenterade-fran-hjartpreservationsstudien-i-australien-nya-zeeland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Positiva resultat presenterade fr\u00e5n hj\u00e4rtpreservationsstudien i Australien & Nya Zeeland"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}